Catalyst Wire Dossier Catalyst Wire Dossier

Hydroxychloroquine + Everolimus (combination)

hydroxychloroquine + everolimus
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hydroxychloroquine + Everolimus (combination), covering 2025-03-05 to 2025-03-05. Get the full timeline:

Most recent: Clinical Trial Update: CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer [Phase 2]

See pricing